Condition
Iliac Vein Stenosis
Total Trials
4
Recruiting
1
Active
1
Completed
2
Success Rate
66.7%-20% vs avg
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 87/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
66.7%
-19.8% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
67% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (4)
Trial Status
Completed2
Recruiting1
Terminated1
Trial Success Rate
66.7%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT04694248Not ApplicableRecruiting
Anticoagulant Plus Antiplatelet Therapy Following Iliac Vein Stenting
NCT05622500Not ApplicableTerminated
Best Endovenous Treatment, Including STenting, Versus Non-endovenous Treatment in Chronic Proximal Deep Venous Disease
NCT04812444Not ApplicableCompletedPrimary
Peripheral Venous Stent System in the Treatment of Iliac Vein Stenosis or Occlusion
NCT05324787Not ApplicableCompletedPrimary
Treatment of Vein Stenosis or Occlusion With the Oblique Stent
Showing all 4 trials